Balyasny Asset Management LLC Cerus Corp Transaction History

Balyasny Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$1.5 - $3.07 $39,346 - $80,529	26,231 New	26,231 $42,000
Q3 2018 Nov 14, 2018	SELL	$6.89 - $7.78 $138,840 - $156,774	-20,151 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $97,826 - $136,655	-18,849 Reduced 48.33%	20,151 $134,000
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $61,232 - $98,728	17,200 Added 78.9%	39,000 $214,000
Q4 2017 Feb 14, 2018	SELL	$2.76 - $3.95 $2,760 - $3,950	-1,000 Reduced 4.39%	21,800 $74,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.73 $50,616 - $62,244	22,800	22,800 $62,000

156

148M

84.2K

55.5K

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $317M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.